-
NIH Gets Into CRISPR/Cas9, Launches $190M Genome Editing Research Program
biospace
January 25, 2018
The National Institutes of Health will launch an effort aimed at removing barriers that slow the adoption of genome editing for treating patients
-
NIH study finds clues about why common cancer drug causes hearing loss
biospectrumasia
December 22, 2017
Researchers find target to protect hearing during chemotherapy treatment
-
NIH public-private PACT aims to fire the Cancer Moonshot boosters
fiercebiotech
October 16, 2017
The National Institutes of Health (NIH) has enlisted the help of 11 top-tier biopharma companies as it pushes towards the goal of cutting the time it takes to bring new cancer immunotherapies to patients in half.
-
NIH launches $215m partnership for cancer immunotherapy strategies
europeanpharmaceuticalreview
October 16, 2017
The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot….
-
NIH awards $100m in funding for research projects on Autism
pharmaceufical-technology
September 11, 2017
The US National Institutes of Health (NIH) has awarded nine research grants worth around $100m over the next five years for the Autism Centres of Excellence (ACE).
-
A vaccine for addiction? Don’t get your hopes up just yet: expert
fiercepharma
August 15, 2017
Tom Price says an NIH vaccine for addiction is "an incredibly exciting prospect," but experts say it's far from reality.
-
Experimental treatment for Niemann-Pick disease type C1 likely to be safe and effective
cphi-online
August 15, 2017
An NIH(National Institutes of Health)research shows that drug slows development of Niemann-Pick disease type C1 (NPC1).
-
Early-stage study gives hope for rare and fatal neurodegenerative condition
pharmafile
August 14, 2017
A team of researchers at Washington University School of Medicine (WUSM) in St Louis and the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (NIH) have revealed the promising ...
-
Numerate receives NIH funding to discover new anti-arrhythmic treatments
pharmaceutical-technology
August 11, 2017
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded a small business innovation research (SBIR) Phase I grant to Numerate to boost new drug programme for cardiac arrhythmias.
-
NYC center receives $7.5 million NIH funds for AIDS research
biospectrumasia
June 15, 2017
The key groups together at the Center will innovate new approaches to treat and control HIV spread in the community.